Table 9.
Sensitivity analysis results for a time horizon of 2 years: variation of costs
| Costs of diagnostic tests* | Additional tests** versus Aptima, n = | Additional costs versus Aptima, € |
|---|---|---|
| Lower value (−25%) | ||
| Hybrid Capture® 2 | 262,443 | 305,247,597.53 € |
| Cobas® 4800 | 269,856 | 2,238,152.57 € |
| Higher value (+ 25%) | ||
| Hybrid Capture® 2 | 262,443 | 476,949,371.14 € |
| Cobas® 4800 | 269,856 | 3,497,113.38 € |
*Includes cytology, colposcopy, and biopsy
**Includes HPV tests and other diagnostic tests (cytology, colposcopy, and biopsy)
Includes the cost of HPV genotyping after the first and subsequent Hybrid Capture® 2 tests